By Professor Michael Proinsias Farrell

Journal articles

Stowe MJ; Conway A; Altice FL; College-Frisby S; Read P; Montebello M; Whitton G; Hayllar J; Daglish M; Cock V; Christmass M; Crawford S; Henderson C; Dore GJ; Gough C; Farrell M; Degenhardt L; Grebely J, 2026, 'Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70079

Darke S; Farrell M; Duflou J; Lappin J; Chrzanowska A; Peacock A, 2026, 'Rates and Clinical Characteristics of Self-Administered Fatal Ketamine-Related Poisoning in Australia, 2000–2025', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70058

Beck AK; Hides L; Stirling R; Larance B; Campbell G; Baker AL; Hudson S; Marsden J; Pocuca N; Connor JP; Farrell M; Kelly PJ, 2026, 'Scoping review of the characteristics and implementation of routine outcome monitoring and feedback for adults and young people accessing alcohol and other drug use treatment', International Journal of Drug Policy, 147, pp. 105071 - 105071, http://dx.doi.org/10.1016/j.drugpo.2025.105071

Varghese C; Peters L; Gaborit L; Xu W; Kalyanasundaram K; Basam A; Park M; Wells C; McLean KA; Schamberg G; O’Grady G; Wright D; Martin J; Harrison E; Pockney P; Reinke C; Kaiser N; Werenski H; Nimeri A; Benham E; Yue T; Knowlton L; Fariyike B; Narayan A; Titan A; Painter M; Craig-Lucas A; Farrell M; Kus ZC; Akbuz SO; Mutlu M; Hokelekli F; Tuzuner F; Durmus E; Cetınkaya ZS; Yilmaz H; Yavuz D; Korkmaz DS; Kazbek BK; Koksoy UC; Şenödeyici E; Aydoğdu EO; Ajredini M; Omur M; Yavuz I; Cakcak IE; Akdere H; Kaya E; Bayram C; Durdu B; Dindar A; Certel AT; Ulkucu A; Sarı AC; Uyanık MS; Candan M; Kara ME; Çolak E; Polat S; Kayilioglu I; Kocyigit GZ; Tabak EZ; Fergar C; Akkaya EN; Baltacı ZH; Uğurlu MÜ; Saraçoğlu A; Aral C; Uprak TK; Kayabaş İ; Elieyioğlu G; Camkıran E; Taşcı ME; Şen E; Korkmaz E; Gemici A; Düzyol Z; Ozbilen M; Gecici ME; Kale A; Selim K; Ulusahin M; Kodalak TA; Kıralı N; Yuzgec AN; Reis ME; Cepe H; Yıldız B; Baysallar D; Guner A; Pehlivan D; Akın B; Gündoğdu A; Tepe MD; Kara Y; Bozkurt MA; Telci H; Sibic O; Ozdemir Z; Uludag SS, 2025, 'Predicting opioid consumption after surgical discharge: a multinational derivation and validation study using a foundation model', Npj Digital Medicine, 8, http://dx.doi.org/10.1038/s41746-025-01798-6

Asare-Doku W; Peacock A; Settumba S; Abbott T; Wilson K; Craig A; Ravulo J; Economidis G; Meo-Sewabu L; D'Este C; Thapa P; Doran C; Nathan S; Waller E; Satour T; Tulele L; Farrell M; Shakeshaft A, 2025, 'Assessing the Early Impact of the Change in the Kava Importation Policy in Australia', Drug and Alcohol Review, 44, pp. 1827 - 1830, http://dx.doi.org/10.1111/dar.70039

Darke S; Duflou J; Lappin J; Farrell M; Peacock A, 2025, 'Characteristics and toxicology of adult deaths due to quetiapine toxicity in Australia, 2000–2024', Journal of Forensic Sciences, 70, pp. 2434 - 2441, http://dx.doi.org/10.1111/1556-4029.70124

Bryant J; Shakeshaft A; Lintzeris N; Haber P; Farrell M; Dizon J; Freund M, 2025, 'Factors Associated With Alcohol Use Among Individuals Commencing Treatment at Community-Based Outpatient Treatment Centres in Australia', Drug and Alcohol Review, 44, pp. 2066 - 2079, http://dx.doi.org/10.1111/dar.70034

Tegge AN; Ferreira MAR; Garafola PM; Xu S; Farrell M; Marsden J; Lee K; Le Moigne A; Gray F; Bickel WK, 2025, 'Treatment and recovery from opioid use disorder: The role of pain severity in individuals with moderate to severe pain', Drug and Alcohol Dependence, 276, http://dx.doi.org/10.1016/j.drugalcdep.2025.112902

Darke S; Farrell M; Duflou J; Copeland C; Roberts E, 2025, 'Drugs and Drowning: The Toxicology of Adult Drownings in Baths and Hot Tubs in Australia, 2015–2024', Drug and Alcohol Review, 44, pp. 1811 - 1815, http://dx.doi.org/10.1111/dar.70005

Economidis G; Lynch M; Taylor S; Asare-Doku W; Macpherson G; Degenhardt L; Farrell M; Santo T, 2025, 'Global Perspectives on Kava: A Narrative Systematic Review of the Health Effects, Economic and Social Impacts and Policy Considerations', Drug and Alcohol Review, 44, pp. 1601 - 1640, http://dx.doi.org/10.1111/dar.14080

Santo TJ; Chaillon A; Martin N; Hickman M; Jones N; Farrell M; Bharat C; Degenhardt L; Borquez A, 2025, 'Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study', Addiction, 120, pp. 1601 - 1609, http://dx.doi.org/10.1111/add.70018

Darke S; Duflou J; Peacock A; Lim J; Havard A; Farrell M; Lappin J, 2025, 'Characteristics of deaths related to lithium toxicity in Australia, 2000–2024', Australian and New Zealand Journal of Psychiatry, 59, pp. 622 - 628, http://dx.doi.org/10.1177/00048674251336037

Darke S; Farrell M; Hall W; Lappin J, 2025, '‘Deaths of despair’: A term that needs to be retired', Addiction, 120, pp. 1072 - 1074, http://dx.doi.org/10.1111/add.70030

Woods A; Foley C; Conigrave KM; Asare-Doku W; Shakeshaft A; Settumba-Stolk S; Farrell M; Doyle M; Stolk SS, 2025, 'Extended-release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review', Addiction, 120, pp. 835 - 859, http://dx.doi.org/10.1111/add.16766

Jones N; Ghouse FN; Gibson A; Tran DT; Santo T; Bharat C; Farrell M; Degenhardt L, 2025, 'Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001–22, New South Wales, Australia', International Journal of Epidemiology, 54, http://dx.doi.org/10.1093/ije/dyaf037

Weatherburn D; Rahman S; Todd S; Poynton S; Black S; Merinda T; Farrell M, 2025, 'The impact of a voluntary alcohol and other drug diversion program on reoffending, imprisonment, and health', International Journal of Drug Policy, 138, pp. 104747, http://dx.doi.org/10.1016/j.drugpo.2025.104747

Darke S; Peacock A; Duflou JA; Farrell M; Lappin J, 2025, 'Methylphenidate and (lis)dexamfetamine toxicity-related deaths of adults, Australia, 2000–24: analysis of NCIS data', Medical Journal of Australia, 222, pp. 259 - 261, http://dx.doi.org/10.5694/mja2.52604

Pocuca N; Campbell G; Barnett A; Beck AK; Ellem R; Quinn CA; Kelly PJ; Larance B; Baker AL; Connor JP; Marsden J; Chan GCK; Connelly L; Lenzen S; Farrell M; Stirling R; Hudson S; Hides L, 2025, 'A mixed-methods study of staff perspectives on the barriers and facilitators to the implementation of patient-reported routine outcome measures and feedback in alcohol and other drug treatment', Drug and Alcohol Review, 44, pp. 759 - 771, http://dx.doi.org/10.1111/dar.14007

Bharat C; Hopkins RE; Chambers M; Degenhardt L; Peacock A; Farrell M; Yuen WS; Man N; Gisev N, 2025, 'Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980–2019', Social Psychiatry and Psychiatric Epidemiology, 60, pp. 693 - 703, http://dx.doi.org/10.1007/s00127-024-02749-4

Santo T; Chaillon A; Martin N; Bharat C; Jones N; Farrell M; Hickman M; Borquez A; Degenhardt L, 2025, 'Quantifying the Impact of Opioid Agonist Treatment on Suicide Mortality in New South Wales, Australia: A Population-Level Analysis from 2001 to 2020', DRUG AND ALCOHOL DEPENDENCE, 267, http://dx.doi.org/10.1016/j.drugalcdep.2024.112133

Darke S; Farrell M; Lappin J, 2025, 'Rare but relevant series', Addiction, 120, pp. 197, http://dx.doi.org/10.1111/add.16697

Darke S; Duflou J; Chrzanowska A; Farrell M; Lappin J; Peacock A, 2025, 'Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001–2023', Drug and Alcohol Review, 44, pp. 366 - 375, http://dx.doi.org/10.1111/dar.13940

Roberts E; Copeland C; Darke S; Farrell M, 2025, 'Characteristics of drug-related deaths where individuals are found submerged in a bath or hot tub in the United Kingdom, 1997–2023', Drug and Alcohol Review, 44, pp. 347 - 354, http://dx.doi.org/10.1111/dar.13950

Darke S; Duflou J; Farrell M; Lappin J; Peacock A, 2025, 'Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000–2025', Addiction, http://dx.doi.org/10.1111/add.70216

Settumba S; Shahbazi J; Byrne M; Degenhardt L; Grebely J; Larance B; Nielsen S; Lintzeris N; Ali R; Rodgers C; Blazey A; Weiss R; Dunlop A; McDonough M; Cook J; Farrell M, 2025, 'Provider costs of treating opioid dependence with extended-release buprenorphine in Australia', Drug and Alcohol Review, 44, pp. 179 - 194, http://dx.doi.org/10.1111/dar.13956

Pocuca N; Tisdale C; Campbell G; Beck AK; Ellem R; Quinn CA; Kelly PJ; Larance B; Baker AL; Connor JP; Marsden J; Chan GCK; Connelly L; Lenzen S; Farrell M; Hides L, 2025, 'Routine outcome monitoring and feedback in alcohol and other drug treatment: A qualitative study of client perspectives on implementation', Drug and Alcohol Review, 44, pp. 226 - 238, http://dx.doi.org/10.1111/dar.13962

Courtney RJ; Howard BC; Barker D; Petrie D; Borland R; Shakeshaft A; Gartner C; Mendelsohn C; Boland VC; Henderson A; Richmond RL; Tutka P; Naughton F; Hall W; Zwar N; Farrell M; Mattick RP; McRobbie H, 2025, 'Vaporized Nicotine Products for Smoking Cessation Among People Experiencing Social Disadvantage A Randomized Clinical Trial', Annals of Internal Medicine, 178, pp. 1085 - 1094, http://dx.doi.org/10.7326/ANNALS-24-03531

Ezard N; Clifford B; Siefried KJ; Ali R; Dunlop A; McKetin R; Bruno R; Carr A; Ward J; Farrell M; Graham R; Haber P; Lubman D; Donoghoe MW; Olsen N; Baker A; Hall M; Arunogiri S; Lintzeris N; Gill A; Rodgers C; Montebello M; Liaw W; Liu Z, 2025, 'Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial', Addiction, 120, pp. 1345 - 1359, http://dx.doi.org/10.1111/add.16730

McKetin R; Degan TJ; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly PJ; Turner A; Clare PJ; Dean OM; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BTF; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Byrne M; Russell S; Zahra E; Berk M, 2024, 'A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial', Trials, 25, http://dx.doi.org/10.1186/s13063-024-08238-y

Zahra E; Darke S; Lappin J; Duflou J; Farrell M, 2024, 'Baclofen-related deaths in Australia 2000–2022', Forensic Science International, 365, http://dx.doi.org/10.1016/j.forsciint.2024.112281

Weatherburn D; Farrell M; Wan WY; Rahman S, 2024, 'The criminal careers of Australian drug traffickers', International Journal of Drug Policy, 134, pp. 104650, http://dx.doi.org/10.1016/j.drugpo.2024.104650

Darke S; Duflou J; Farrell M; Lappin J; Peacock A, 2024, 'Emergence of deaths due to nitazene toxicity in Australia', Drug and Alcohol Review, 43, pp. 2093 - 2094, http://dx.doi.org/10.1111/dar.13920

Farnbach S; Foley C; Gates P; Seccull A; Henderson A; Zocco A; Farrell M; Shakeshaft A, 2024, 'Enhancing the SUSTAINable uptake of evidence to minimise harms from alcohol and other drugs in New South Wales, Australia', Drug and Alcohol Review, 43, pp. 1781 - 1786, http://dx.doi.org/10.1111/dar.13843

Heijstee N; Black E; Black E; Demirkol A; Mammen K; Mills L; Deacon R; Ezard N; Montebello M; Reid D; Bruno R; Shakeshaft A; Siefried KJ; Farrell M; Lintzeris N, 2024, 'Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia', Journal of Addiction Medicine, 18, pp. 619 - 627, http://dx.doi.org/10.1097/ADM.0000000000001311

Wardle H; Degenhardt L; Marionneau V; Reith G; Livingstone C; Sparrow M; Tran LT; Biggar B; Bunn C; Farrell M; Kesaite V; Poznyak V; Quan J; Rehm J; Rintoul A; Sharma M; Shiffman J; Siste K; Ukhova D; Volberg R; Salifu Yendork J; Saxena S, 2024, 'The Lancet Public Health Commission on gambling', Lancet Public Health, 9, pp. e950 - e994, http://dx.doi.org/10.1016/S2468-2667(24)00167-1

Darke S; Duflou J; McDonald S; Peacock A; Farrell M; Lappin J, 2024, 'Neuropathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Dependence, 263, http://dx.doi.org/10.1016/j.drugalcdep.2024.111407

Darke S; Duflou J; Peacock A; Farrell M; Hall W; Lappin J, 2024, 'A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia', Addiction, 119, pp. 1564 - 1571, http://dx.doi.org/10.1111/add.16518

Macdonald C; Macpherson G; Leppan O; Tran LT; Cunningham EB; Hajarizadeh B; Grebely J; Farrell M; Altice FL; Degenhardt L, 2024, 'Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis', Lancet Public Health, 9, pp. e684 - e699, http://dx.doi.org/10.1016/S2468-2667(24)00160-9

Gaborit L; Kalyanasundaram K; Vu J; Basam A; Elhadi M; Wright D; Martin J; Park M; Pockney P; Ntalouka M; Abubaker N; Elhadi M; Saeed U; Abdulwahed E; Alsori M; Alrifae GMH; Farrell M; Liu G; Smith N; Xu W; Varghese C; Harrison E; Goh S; Li J; Shah J; Waraich A; Pathak U; Hilder A; Elhadi M; Jabur A; Ohis C; Ong CF; Siribaddana V; Raubenheimer K; Wells C; Ferguson L; Xu W; Pockney P; Atherton K; Dawson A; Martin J; Banerjee A; Dudi-Venkata N; Lightfoot N; Ludbrook I; Peters L; Sara R; Watson D; Adeyeye A; Alvarez-Lozada LA; Atici SD; Buhavac M; Calini G; Elhadi M; Ioannidis O; Tepe MD; Nath U; Uzair A; Yang W; Zaidi F; Singh S; Abdullah B; Palacios DSG; Ragab A; Ahmed A; Daudu D; Goh S; Benyani SV; Karthikeyan N; Mansour LT; Seow W; Tasi Z; Abdelmelek DE; Boussahel IFZ; Kaabache O; Lemdaoui N; Nebbar O; Rais M; Abdoun M; Kouicem AT; Bouaoud S; Bouchenak K; Saada H; Ouyahia A; Messai W; Choong ZS; Ting C; Larkin M, 2024, 'Patterns of opioid use after surgical discharge: a multicentre, prospective cohort study in 25 countries', Anaesthesia, 79, pp. 924 - 936, http://dx.doi.org/10.1111/anae.16297

Tran LT; Wardle H; Colledge-Frisby S; Taylor S; Lynch M; Rehm J; Volberg R; Marionneau V; Saxena S; Bunn C; Farrell M; Degenhardt L, 2024, 'The prevalence of gambling and problematic gambling: a systematic review and meta-analysis', Lancet Public Health, 9, pp. e594 - e613, http://dx.doi.org/10.1016/S2468-2667(24)00126-9

Darke S; Farrell M; Duflou J; Lappin J, 2024, 'Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications', Addiction, 119, pp. 1153 - 1155, http://dx.doi.org/10.1111/add.16407

Bharat C; Farrell M, 2024, 'National approaches to reduce mortality after prison release', Lancet Public Health, 9, pp. e412 - e413, http://dx.doi.org/10.1016/S2468-2667(24)00105-1

Lawson S; Bryant J; Freund M; Dizon J; Haber PS; Shakeshaft A; Jefferies M; Farrell M, 2024, 'Prevalence and factors associated with polydrug use among clients seeking treatment for alcohol misuse', Drug and Alcohol Review, 43, pp. 1194 - 1203, http://dx.doi.org/10.1111/dar.13833

Clay S; Wilkinson Z; Ginley M; Arunogiri S; Christmass M; Membrey D; MacCartney P; Sutherland R; Colledge-Frisby S; Marshall AD; Nagle J; Degenhardt L; Farrell M; McKetin R, 2024, 'The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia', Drug and Alcohol Review, 43, pp. 1313 - 1322, http://dx.doi.org/10.1111/dar.13853

Webb P; Ireland J; Colledge-Frisby S; Peacock A; Leung J; Vickerman P; Farrell M; Hickman M; Grebely J; Degenhardt L, 2024, 'Patterns of drug use among people who inject drugs: A global systematic review and meta-analysis', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104455

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Darke S; Duflou J; Peacock A; Chrzanowska A; Yuen WS; Farrell M; Lappin J, 2024, 'Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Review, 43, pp. 937 - 945, http://dx.doi.org/10.1111/dar.13817

Tran AD; Grebely J; Chambers M; Degenhardt L; Farrell M; Bajis S; Larance B, 2024, 'Health utility among people who regularly use opioids in Australia', Drug and Alcohol Review, 43, pp. 997 - 1012, http://dx.doi.org/10.1111/dar.13823

Black N; Chung S; Tisdale C; Fialho LS; Aramrattana A; Assanangkornchai S; Blaszczynski A; Bowden-Jones H; van den Brink W; Brown A; Brown QL; Cottler LB; Elsasser M; Ferri M; Florence M; Gueorguieva R; Hampton R; Hudson S; Kelly PJ; Lintzeris N; Murphy L; Nadkarni A; Neale J; Rosen D; Rumpf HJ; Rush B; Segal G; Shorter GW; Torrens M; Wait C; Young K; Farrell M, 2024, 'An International, Multidisciplinary Consensus Set of Patient-Centered Outcome Measures for Substance-Related and Addictive Disorders', Journal of Clinical Medicine, 13, http://dx.doi.org/10.3390/jcm13072154

Hall W; Darke S; Farrell M, 2024, 'Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?', Addiction, 119, pp. 786 - 787, http://dx.doi.org/10.1111/add.16416

Back to profile page